Viking Therapeutics is targeting two monster markets. David Jagielski (CRISPR Therapeutics): Biotech company CRISPR ...

Nvidia completed its 10-for-1 stock split on June 7 of last year, with shares trading at the split-adjusted price as of June ...

The stock needs a compound annual growth rate of 12.2% to double in the next six years. Novo Nordisk can pull it off, ...

While Lucid is likely to give back some of Thursday's large gains, there's little stopping Lucid's stock from climbing higher ...

Both Realty Income and W.P. Carey own single-tenant properties for which the tenant is responsible for most property-level ...

Lucid EVs will be equipped with the Nuro Driver Level 4 autonomy system, according to the deal's press release. Nuro is using ...

Alphabet is an eclectic collection of tech-centric businesses. Unfortunately, there isn't one stock to rule them all.

There are plenty of reasons Wall Street is obsessed. Let's look at a few of those reasons and what they mean for investors.

It might be prudent to make a point of collecting a little more cash in the near future, and worry a little less about growth ...

IonQ has emerged as a top competitor in this space primarily due to its short-term success and its partnerships. Quantum ...

This is why investors shouldn't be afraid to buy quality growth stocks at a new high. What matters is understanding the ...

Artificial intelligence (AI) investing remains at the forefront of the market as companies continue to invest billions of ...